Jason Hoitt

Insider Reports History

Location
Bedford, MA
Signature
/s/ Jonathan Allan, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Jason Hoitt:

Company Role Class Num Shares Value Price $ Report Date Ownership
Stoke Therapeutics, Inc. Chief Patient Officer Common Stock 1,802 $16,091 $8.93 18 Jun 2025 Direct
Provention Bio, Inc. Chief Commercial Officer Common Stock 0 $24.32 10 Feb 2023 Direct
Provention Bio, Inc. Chief Commercial Officer Option to Purchase Common Stock 0 27 Apr 2023 Direct

Insider Reports Filed by Jason Hoitt

Symbol Company Period Transactions Value $ Form Type Role Filing Time
STOK Stoke Therapeutics, Inc. 18 Jun 2025 0 $0 3 Chief Patient Officer 23 Jun 2025, 16:16
/report/000149315223013904-hoitt-jason-2023-04-27 Provention Bio, Inc. 27 Apr 2023 5 $0 4 Chief Commercial Officer 27 Apr 2023, 18:00
/report/000149315223005078-hoitt-jason-2023-02-10 Provention Bio, Inc. 10 Feb 2023 1 -$45,005 4 Chief Commercial Officer 14 Feb 2023, 18:16
/report/000149315223001208-hoitt-jason-2023-01-10 Provention Bio, Inc. 10 Jan 2023 1 $0 4 Chief Commercial Officer 11 Jan 2023, 20:10
/report/000149315222035096-hoitt-jason-2022-12-08 Provention Bio, Inc. 08 Dec 2022 2 $0 4 Chief Commercial Officer 09 Dec 2022, 19:31
/report/000149315222001752-hoitt-jason-2022-01-18 Provention Bio, Inc. 18 Jan 2022 1 $0 4 Chief Commercial Officer 20 Jan 2022, 16:20
/report/000149315221011579-hoitt-jason-2021-05-12 Provention Bio, Inc. 12 May 2021 1 $0 4 Chief Commercial Officer 14 May 2021, 19:39